Kicking off the year with a new round of #GI and #kidneydisease meetings! See where the team will be this January.
Ardelyx, Inc.
Biotechnology Research
Waltham, MA 16,715 followers
Translating Scientific Breakthroughs into Promise for Patients
About us
Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been submitted in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. Community Guidelines: https://rb.gy/07ltg3
- Website
-
http://www.ardelyx.com
External link for Ardelyx, Inc.
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Waltham, MA
- Type
- Public Company
- Founded
- 2007
Locations
-
Primary
Get directions
400 Fifth Avenue
210
Waltham, MA 02451, US
-
Get directions
34175 Ardenwood Blvd
Fremont, CA 94555, US
-
Get directions
260 E Highland Ave
Milwaukee, Wisconsin 53202, US
Employees at Ardelyx, Inc.
Updates
-
Hyperphosphatemia, or a high level of phosphorus in the blood, is a serious condition that affects the majority of chronic kidney disease patients on dialysis in the U.S. Hear from Quiana, who is living with #kidneydisease, as she shares her experience managing high phosphorus: https://bit.ly/46UZYRd
-
Team Ardelyx is wishing you health and happiness this holiday season! Thank you for being part of our vision to create a healthier tomorrow for patients with unmet medical needs. We look forward to continuing this journey with you in 2025! #HappyHolidays
-
-
Team Ardelyx is giving back this holiday season! We're honored to have recently partnered with Life Science Cares Boston to host a holiday gift drive, benefiting Julie's Family Learning Program. Thanks to the generosity of our team, we were able to donate 150 toys and gift cards! #ArdelyxProud #ArdelyxACTS
So. Many. Toys. The team at Ardelyx, Inc. made gifts possible for dozens of families at Julie's Family Learning Program this holiday season. They are fantastic #HolidayHelpers!
-
-
Check out the latest episode of Gut Matters: Discoveries and Innovations to learn more about the gut-brain axis and how holiday stress may be impacting your #IBS symptoms. Subscribe wherever you get your podcasts. Listen Now: https://bit.ly/4dHvWBY
-
We’re proud to sponsor Gastro Girl's recent podcast episode: “IBS-C Diagnostic Criteria and Tools: What Providers Need to Know,” featuring Dr. Kyle Staller, Gastroenterologist and Neurogastroenterologist at Mass General. Tune in for expert insights and practical strategies to support IBS-C patients: https://bit.ly/3OCSQ3k
-
-
We're seeking individuals committed to advancing patient care. Learn more about our latest openings in Investor Relations, Information Technology, Business Development and more. See here: https://bit.ly/47wO28y #careers #biotech
-
Those living with #IBS-C often feel stigmatized. Discussing bowel habits is not thought of as an “acceptable” topic of conversion, and a patient's dietary restrictions can leave them feeling isolated. Hear from Tina, in her own words, about her life with IBS-C, how she found her voice and gained support from the IBS-C community. Read here: https://bit.ly/3YWynwX
-
We’re proud to sponsor Gastro Girl's recent podcast episode: “How to Manage IBS-C: Expert Insight on Treatments and Symptom Relief,” featuring Dr. Lin Chang, a leading expert in neurogastroenterology and the gut-brain connection. Give it a listen: https://bit.ly/3ZeLyZM
-
-
Wrapping up the year with another month full of #GI and #kidneydisease meetings. Check out where Team Ardelyx will be throughout the month of December!